Journal Report

Biomolecules and Biomedicine

Download PDF
Journal Information
Journal Title
Biomolecules and Biomedicine
Publisher
Association of Basic Medical Sciences of FBIH
ISSN
2831-0896
E-ISSN
2831-090X
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023
2021/2022
2020
2019
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
SARS-CoV-2 variants and cardiovascular complications – Implications for surveillance and vaccination: A narrative review
Francesco Nappi
2026-11-9
Patient-level EEG seizure classification with AHCNet: Hybrid CNN and handcrafted feature fusion
Saloua Ben Younes, Souhir Chabchoub, Mazin Abed Mohammed et al.
2026-11-9
Epigenetic mechanisms in disseminated tumor cell dormancy and reactivation: A scoping review
Jeremy Gray, Angel Biju, Ghaith Al-Eyd et al.
2026-11-9
Reduced apelin expression and atrial fibrosis in postoperative atrial fibrillation following coronary artery bypass grafting
Yijun Xu, Zhiqiang Chen, Peng Liu et al.
2026-11-6
Hannibal ante portas: B7-H3-directed therapies at the gates of precision oncology
Krešimir Tomić, Semir Vranić
2026-11-4
Book of abstracts: The role of exercise in managing immunotherapy-related chronic fatigue during cancer treatment. Online symposium, Cologne, Germany, 6 November 2026
Organizing Committee of the Symposium
2026-10-31
Farnesol, lyticase, and tyrosol against <i>Candida albicans</i> biofilms: Interactions with fluconazole and micafungin
İmdat Kılbaş, Esra Yıldırım Servi, Meltem Uzun
2026-10-30
Glasdegib and inotuzumab ozogamicin in B-cell acute lymphoblastic leukemia: Assessing drug responses in a stromal co-culture model
David W. Woolston, Michael Churchill, Carla Grandori et al.
2026-10-28
Predicting 30-day mortality in upper gastrointestinal bleeding using APUA components and lactate: Development and internal validation
Murat Das, Ozge Kurtkulagi, Ece Unal et al.
2026-10-27
Time-varying association of first-line bevacizumab with progression-free survival in advanced ovarian cancer: A multicenter matched cohort study
Kristina Katić, Dora Čerina Pavlinović, Ivana Canjko et al.
2026-10-26
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 11, 2026 11:14